A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Clinical trial NCT02627274 · COMPLETED

Trial details

NCT number: NCT02627274
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Breast Cancer Cancer of Head and Neck

Start date: 2015-12-07
Primary completion: 2022-11-10
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.